| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| A0A024QZM2 | Leucine rich repeat containing 20, isoform CRA_b; | LRRC20; | NULL | 184 | human |
| Q5FC02 | IL6ST nirs variant 6; Interleukin-6 receptor subunit beta; | IL6ST; | NULL | 66 | human |
| A6NGS0 | Ubiquitin-conjugating enzyme E2 J2; Ubiquitin-conjugating enzyme E2, J2 (UBC6 homolog, yeast), isoform CRA_e; | UBE2J2; | NP_919439.1;NP_919440.1; | 207 | human |
| Q5NV65 | V1-5 protein; Fragment; | V1-5; | NULL | 99 | human |
| A0A024QZD2 | SH2-B homolog, isoform CRA_c; | SH2B; | NULL | 756 | human |
| Q13629 | HCG1987479; Putative uncharacterized protein unknown; | unknown; | NULL | 118 | human |
| D3DRQ8 | HCG2036546, isoform CRA_a; | NULL | NULL | 97 | human |
| A0A024RAY7 | Pleckstrin homology domain containing, family A member 5, isoform CRA_a; | PLEKHA5; | NULL | 1174 | human |
| A0A024R7N4 | Regulator of G-protein signalling 14, isoform CRA_a; | RGS14; | NULL | 567 | human |
| Q9BZU3 | Cyclin-dependent kinases regulatory subunit; | CKS1B; | NULL | 63 | human |
| H0UI99 | Zinc finger, CCCH-type with G patch domain, isoform CRA_b; | ZGPAT; | NULL | 502 | human |
| Q5TDX8 | SUN domain-containing protein 5; Sperm associated antigen 4-like, isoform CRA_a; | SUN5; SPAG4L; | NULL | 122 | human |
| H0UIC5 | Ecotropic viral integration site 2B, isoform CRA_a; | EVI2B; | NULL | 368 | human |
| C9JLS9 | 26S protease regulatory subunit 7; Fragment; | PSMC2; | NULL | 130 | human |
| A0A024QYV2 | HCG1983280, isoform CRA_a; Fragment; | NULL | NULL | 182 | human |
| A0A024R965 | Protein phosphatase 1, regulatory (Inhibitor) subunit 12B, isoform CRA_a; | PPP1R12B; | NULL | 91 | human |
| C9IZF4 | HCG14948, isoform CRA_a; Serine/threonine-protein phosphatase 4 regulatory subunit 2; | PPP4R2; | NULL | 69 | human |
| E9PIK2 | Artemin; Fragment; | ARTN; | NULL | 66 | human |
| A0A024R6U4 | Bardet-Biedl syndrome 2, isoform CRA_a; | BBS2; | NULL | 721 | human |
| A0A024RBJ3 | Anaphase promoting complex subunit 7, isoform CRA_b; | ANAPC7; | NULL | 599 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |